These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11344825

  • 1. Effects of estrogen/medrogestone therapy on the apoprotein B-containing lipoproteins in postmenopausal women with type 2 diabetes mellitus under satisfactory and non-satisfactory glycemic control.
    Aguilar-Salinas CA, Arita Melzer O, Sauque Reyna L, Lopez A, Velasco Perez ML, Guillen LE, Gomez Perez FJ, Rull Rodrigo JA.
    Isr Med Assoc J; 2001 Feb; 3(2):137-43. PubMed ID: 11344825
    [Abstract] [Full Text] [Related]

  • 2. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 3. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR, Goldstat R, Newman A, Berry K, Burger HG, Meredith I, Koch K.
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [Abstract] [Full Text] [Related]

  • 4. Effect of estrogen on the size of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A, Ikenoue N, Sagara Y.
    Obstet Gynecol; 1997 Jul; 90(1):22-5. PubMed ID: 9207806
    [Abstract] [Full Text] [Related]

  • 5. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC, Lien YR, Chen M, Cheng SP, Chen RJ, Chow SN.
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [Abstract] [Full Text] [Related]

  • 6. Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?
    McKenzie J, Jaap AJ, Gallacher S, Kelly A, Crawford L, Greer IA, Rumley A, Petrie JR, Lowe GD, Paterson K, Sattar N.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):682-9. PubMed ID: 14974908
    [Abstract] [Full Text] [Related]

  • 7. The effect of hormone replacement therapy on the levels of serum lipids, apolipoprotein AI, apolipoprotein B and lipoprotein (a) in Turkish postmenopausal women.
    Bayrak A, Aldemir DA, Bayrak T, Corakçi A, Dursun P.
    Arch Gynecol Obstet; 2006 Aug; 274(5):289-96. PubMed ID: 16810536
    [Abstract] [Full Text] [Related]

  • 8. Effects of conjugated equine estrogens or raloxifene on lipid profile, coagulation and fibrinolysis factors in postmenopausal women.
    Dias AR, Melo RN, Gebara OC, D'Amico EA, Nussbacher A, Halbe HW, Pinotti JA.
    Climacteric; 2005 Mar; 8(1):63-70. PubMed ID: 15804733
    [Abstract] [Full Text] [Related]

  • 9. [Effect of combined conjugated estrogen-medrogestone replacement therapy on lipid profiles, climacteric symptoms and the endometrium].
    Belaisch J, Nappi C, Affinito P, De Gezelle H, Botelho M, Oliveira HM, Martinez-Oliveira J, Gonzaga F.
    J Gynecol Obstet Biol Reprod (Paris); 2000 Feb; 29(1):29-40. PubMed ID: 10675831
    [Abstract] [Full Text] [Related]

  • 10. Effect of lower dose of oral conjugated equine estrogen on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women.
    Wakatsuki A, Okatani Y, Ikenoue N, Shinohara K, Watanabe K, Fukaya T.
    Circulation; 2003 Aug 19; 108(7):808-13. PubMed ID: 12900341
    [Abstract] [Full Text] [Related]

  • 11. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H, Goyal RK.
    Indian Heart J; 2001 Aug 19; 53(2):172-6. PubMed ID: 11428472
    [Abstract] [Full Text] [Related]

  • 12. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A, Del Prato S, Bue-Valleskey J, Beattie S, Gates J, de la Peña A, Malone J.
    J Diabetes Complications; 2007 Aug 19; 21(1):20-7. PubMed ID: 17189870
    [Abstract] [Full Text] [Related]

  • 13. A randomized, open-label study of conjugated equine estrogens plus medroxyprogesterone acetate versus tibolone: effects on symptom control, bleeding pattern, lipid profile and tolerability.
    Baracat EC, Barbosa IC, Giordano MG, Haidar MA, Marinho RM, Menegocci JC, Morais KM, Tomaz G, Wehba S.
    Climacteric; 2002 Mar 19; 5(1):60-9. PubMed ID: 11974560
    [Abstract] [Full Text] [Related]

  • 14. The hypoglycemic effects of soy isoflavones on postmenopausal women.
    Cheng SY, Shaw NS, Tsai KS, Chen CY.
    J Womens Health (Larchmt); 2004 Dec 19; 13(10):1080-6. PubMed ID: 15650341
    [Abstract] [Full Text] [Related]

  • 15. Effects of continuous combined conjugated estrogen/medroxyprogesterone acetate and 17beta-estadiol/norethisterone acetate on lipids and lipoproteins.
    Odmark IS, Bäckström T, Haeger M, Jonsson B, Bixo M.
    Maturitas; 2004 Jun 15; 48(2):137-46. PubMed ID: 15172088
    [Abstract] [Full Text] [Related]

  • 16. Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy.
    Shepherd J, Packard C, Littlejohn TW, Walker J, Stein EA, Smith K, Kallend D, Blasetto JW.
    Curr Med Res Opin; 2004 Oct 15; 20(10):1571-8. PubMed ID: 15462690
    [Abstract] [Full Text] [Related]

  • 17. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
    Bingol B, Gunenc Z, Yilmaz M, Biri A, Tiras B, Güner H.
    Arch Gynecol Obstet; 2010 May 15; 281(5):857-64. PubMed ID: 19593578
    [Abstract] [Full Text] [Related]

  • 18. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T, Creatsas G, Rechberger T, Depypere H, Erenus M, Quail D, Arndt T, Bonnar J, Euralox 1 Study Group.
    Climacteric; 2001 Dec 15; 4(4):320-31. PubMed ID: 11770189
    [Abstract] [Full Text] [Related]

  • 19. Effects of short-term modest weight loss on fasting and post-prandial lipoprotein sub-fractions in type 2 diabetes mellitus patients.
    Ybarra J, James RW, Makoundou V, Bioletto S, Golay A.
    Diabetes Metab; 2001 Dec 15; 27(6):701-8. PubMed ID: 11852380
    [Abstract] [Full Text] [Related]

  • 20. Hormone-replacement therapy increases serum paraoxonase arylesterase activity in diabetic postmenopausal women.
    Sutherland WH, Manning PJ, de Jong SA, Allum AR, Jones SD, Williams SM.
    Metabolism; 2001 Mar 15; 50(3):319-24. PubMed ID: 11230785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.